Literature DB >> 6177392

Paraplegia following intrathecal chemotherapy: neuropathologic findings and elevation of myelin basic protein.

A W Clark, S R Cohen, M J Nissenblatt, S K Wilson.   

Abstract

An 11-year-old boy developed a severe myelopathy after an eight-year history of acute lymphoblastic leukemia and numerous courses of intrathecal chemotherapy. Myelin basic protein in the cerebrospinal fluid (CSF) was elevated. Neuropathologic examination disclosed extensive microvacuolar changes in the white matter of the spinal cord. The pathogenesis of myelopathy following intrathecal chemotherapy administered by lumbar puncture includes an early effect on the myelin sheath. Serial assessment of CSF myelin basic protein levels in patients receiving intrathecal chemotherapy may be useful in the early diagnosis of this disorder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177392     DOI: 10.1002/1097-0142(19820701)50:1<42::aid-cncr2820500109>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.

Authors:  France Ziereisen; Bernard Dan; Nadira Azzi; Alina Ferster; Nash Damry; Catherine Christophe
Journal:  Pediatr Radiol       Date:  2005-12-21

Review 2.  The toxicity of cytarabine.

Authors:  J Stentoft
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

Review 3.  Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review.

Authors:  Nikolaos Kougkas; Athanasia Dara; Eleni Pagkopoulou; Androniki Dimitriadou; Evdokia Papadimitriou; Eugenia Avdelidou; Alexandros Garyfallos; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2022-07-18       Impact factor: 3.580

4.  Necrotising leukoencephalopathy complicating treatment of childhood leukaemia.

Authors:  O Robain; O Dulac; J P Dommergues; F Bernaudin; K Diebler; C Kalifa; J Poirier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-01       Impact factor: 10.154

5.  Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.

Authors:  A Olivi; M Gilbert; K L Duncan; B Corden; D Lenartz; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Irreversible paraplegia following one time prophylactic intrathecal chemotherapy in an adult patient with acute lymphoblastic leukemia.

Authors:  Hea Yong Lee; Sung-il Im; Myoung-Hee Kang; Kwang Min Kim; Seok Hyun Kim; Hun-Gu Kim; Jung Hun Kang; Gyeong-Won Lee
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

7.  Acute reversible neurological deficit following intrathecal chemotherapy.

Authors:  H Dunkelman; H M Earl; C Twelves
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Methotrexate myelopathy after intrathecal chemotherapy: a case report.

Authors:  Ken-ya Murata; Ayaka Maeba; Mika Yamanegi; Ichiro Nakanishi; Hidefumi Ito
Journal:  J Med Case Rep       Date:  2015-06-09

9.  Ascending sensory motor polyradiculoneuropathy with cranial nerve involvement following administration of intrathecal methotrexate and intravenous cytarabine in a patient with acute myelogenous leukemia: a case report*.

Authors:  Richard A Rison
Journal:  Cases J       Date:  2008-10-21

10.  Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department.

Authors:  Maria Teresa Cruz-Carreras; Patrick Chaftari; Anna Shamsnia; Nandita Guha-Thakurta; Carmen Gonzalez
Journal:  Clin Case Rep       Date:  2017-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.